
  
    
      
        Background_NNP
        The_DT replicative_JJ polymerase_NN of_IN herpes_NNS simplex_NN virus_NN (_( HSV_NNP )_)
        is_VBZ comprised_VBN of_IN catalytic_JJ (_( Pol_NNP )_) and_CC processivity_NN subunits_NNS
        (_( UL_NNP 42_CD )_) [_NN 9_CD 11_CD ]_NN ._. HSV_NNP Pol_NNP is_VBZ responsible_JJ ,_, in_IN concert_NN with_IN
        other_JJ viral_JJ proteins_NNS ,_, for_IN regulating_VBG the_DT fidelity_NN of_IN DNA_NNP
        replication_NN by_IN selecting_VBG the_DT correct_JJ nucleotides_NNS for_IN
        incorporation_NN and_CC by_IN proofreading_VBG or_CC editing_NN mispaired_JJ
        nucleotides_NNS [_NN 20_CD ]_NN ._. The_DT Pol_NNP subunit_NN contains_VBZ intrinsic_JJ
        3_CD '_POS -_: 5_CD '_POS exonuclease_NN activity_NN [_NN 14_CD 15_CD 16_CD ]_NN and_CC the_DT N-_NNP terminal_NN
        region_NN of_IN the_DT polypeptide_NN encoding_VBG this_DT function_NN is_VBZ highly_RB
        conserved_JJ in_IN other_JJ polymerases_NNS ,_, containing_VBG three_CD segments_NNS
        referred_VBD to_TO as_IN Exo_NNP motifs_NNS [_NN 3_CD 26_CD ]_NN ._.
        Thymidine_NNP kinase_NN polypeptide_NN (_( TK_NNP )_) is_VBZ required_VBN for_IN the_DT
        activation_NN of_IN some_DT antiviral_JJ nucleoside_NN analogs_NNS e_SYM ._. g_SYM ._.
        acyclovir_NN (_( ACV_NNP )_) and_CC penciclovir_NN (_( PCV_NNP )_) ,_, in_IN order_NN to_TO inhibit_VB
        viral_JJ DNA_NNP replication_NN ._. HSV_NNP with_IN TK_NNP mutations_NNS may_MD impair_VB
        activation_NN of_IN these_DT drugs_NNS and_CC confer_VB a_DT drug-resistant_JJ
        phenotype_NN ._. The_DT natural_JJ phenomenon_NN of_IN spontaneous_JJ mutation_NN ,_,
        which_WDT occurs_VBZ in_IN the_DT absence_NN of_IN drug_NN selection_NN ,_, results_NNS in_IN
        the_DT accumulation_NN of_IN approximately_RB six_CD to_TO eight_CD TK-deficient_NNP
        variants_NNS per_IN 10_CD 4_CD plaque-forming_JJ viruses_NNS in_IN virus_NN
        populations_NNS that_WDT have_VBP never_RB been_VBN exposed_VBN to_TO selective_JJ
        pressure_NN [_NN 6_CD 10_CD 12_CD ]_NN ._. Furthermore_RB ,_, HSV-_NNP 2_CD clinical_JJ isolates_VBZ
        were_VBD shown_VBN to_TO have_VB a_DT higher_JJR frequency_NN of_IN spontaneous_JJ
        mutations_NNS resistant_JJ to_TO ACV_NNP and_CC PCV_NNP ,_, approximately_RB 30_CD -_: fold_VB ,_,
        compared_VBN to_TO HSV-_NNP 1_CD isolates_VBZ ,_, and_CC the_DT majority_NN of_IN these_DT
        mutations_NNS are_VBP in_IN 
        tk_NN ._. Consistent_NNP with_IN this_DT
        observation_NN ,_, HSV-_NNP 2_CD strains_NNS also_RB exhibited_VBN approximately_RB a_DT
        20_CD -_: to_TO 80_CD -_: fold_VB higher_JJR spontaneous_JJ mutation_NN rate_NN to_TO
        cidofovir_NN (_( HPMPC_NNP )_) ,_, an_DT inhibitor_NN of_IN HSV_NNP Pol_NNP ,_, resistance_NN
        compared_VBN with_IN HSV-_NNP 1_CD [_NN 21_CD ]_NN ._. Therefore_RB ,_, these_DT
        naturally-occuring_JJ mutations_NNS are_VBP not_RB unique_JJ to_TO 
        tk_NN and_CC TK_NNP substrates_NNS as_IN detected_VBN with_IN
        antiviral_JJ agents_NNS ACV_NNP and_CC PCV_NNP ,_, but_CC were_VBD extended_VBN with_IN the_DT
        direct_JJ Pol_NNP inhibitor_NN ,_, HPMPC_NNP ,_, to_TO other_JJ loci_NN ,_, most_RBS likely_JJ 
        pol_NN ._.
        Since_IN mutations_NNS within_IN the_DT viral_JJ 
        pol_NN gene_NN have_VBP been_VBN previously_RB shown_VBN
        to_TO affect_VB spontaneous_JJ viral_JJ mutation_NN rates_NNS [_NN 10_CD ]_NN ,_, the_DT
        higher_JJR frequency_NN of_IN errors_NNS associated_VBN with_IN type_NN 2_CD viruses_NNS
        may_MD be_VB an_DT inherent_JJ property_NN of_IN the_DT type_NN 2_CD Pol_NNP ._. To_TO assess_VB
        the_DT direct_JJ contribution_NN of_IN polymerases_NNS from_IN virus_NN types_NNS 1_CD
        and_CC 2_CD to_TO mutation_NN frequency_NN ,_, recombinant_JJ HSV_NNP expressing_VBG a_DT
        type_NN 2_CD Pol_NNP within_IN a_DT type_NN 1_CD viral_JJ genome_NN were_VBD generated_VBN by_IN
        marker_NN transfer_NN and_CC examined_VBD along_IN with_IN a_DT panel_NN of_IN other_JJ
        HSV_NNP isolates_VBZ in_IN two_CD mutagenesis_NNS assays_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Cell_NNP lines_NNS ,_, compounds_NNS and_CC viruses_NNS
          Vero_NNP (_( ATCC_NNP ,_, passage_NN 15_CD -_: 20_CD )_) ,_, MRC-_NNP 5_CD (_( ATCC_NNP ,_, passage_NN
          12_CD -_: 15_CD )_) and_CC PolB_NNP 3_CD (_( kind_NN gift_NN of_IN D_NNP ._. Coen_NNP ,_, Harvard_NNP
          University_NNP ,_, Boston_NNP MA_NNP )_) cell_NN lines_NNS were_VBD grown_VBN in_IN
          Dulbecco_NNP 's_POS Modified_NNP Eagle_NNP 's_POS Medium_NNP (_( DMEM_NNP )_) supplemented_JJ
          with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN (_( FCS_NNP )_) and_CC incubated_JJ at_IN 37_CD °_NN C_NNP ,_,
          5_CD %_NN CO_NNP 
          2_CD ._. PolB_NNP 3_CD represents_VBZ a_DT Vero_NNP cell_NN line_NN
          constitutively_RB expressing_VBG the_DT HSV-_NNP 1_CD Pol_NNP [_NN 17_CD ]_NN ._. PCV_NNP was_VBD
          synthesized_JJ at_IN SmithKline_NNP Beecham_NNP Pharmaceuticals_NNP ._. ACV_NNP
          used_VBD in_IN these_DT studies_NNS was_VBD obtained_VBN from_IN Sigma_NNP (_( St_NNP ._. Louis_NNP ,_,
          MO_NNP )_) ._. For_IN cell_NN culture_NN assays_NNS ,_, 10_CD mg_NN /_NN ml_NN stock_NN solutions_NNS
          were_VBD prepared_VBN in_IN dimethyl_NN sulphoxide_NN (_( DMSO_NNP )_) and_CC stored_VBD at_IN
          -_: 20_CD °_NN C_NNP ._. Working_JJ dilutions_NNS were_VBD prepared_VBN in_IN assay_NN medium_NN
          immediately_RB before_IN use_NN as_IN described_VBN below_IN ._. HSV-_NNP 1_CD strain_NN
          SC_NNP 16_CD (_( wild_JJ type_NN laboratory_NN virus_NN )_) ,_, HSV-_NNP 2_CD SB_NNP 5_CD (_( wild_JJ type_NN
          laboratory_NN virus_NN )_) ,_, HSV-_NNP 2_CD 6652_CD (_( wild_JJ type_NN clinical_JJ virus_NN )_) ,_,
          HSV-_NNP 2_CD 83_CD D_NNP (_( wild_JJ type_NN clinical_JJ virus_NN )_) ,_, HSV-_NNP 2_CD 6757_CD (_( high_JJ
          error_NN mutant_JJ clinical_JJ virus_NN )_) were_VBD described_VBN previously_RB [_NN
          21_CD ]_NN and_CC the_DT HSV-_NNP 1_CD PAA_NNP r_LS 5_CD (_( antimutator_NN laboratory_NN virus_NN )_)
          utilized_JJ in_IN this_DT study_NN was_VBD a_DT kind_NN gift_NN of_IN D_NNP ._. Coen_NNP
          (_( Harvard_NNP University_NNP ,_, Boston_NNP ,_, MA_NNP )_) [_NN 10_CD ]_NN ._. HP_NNP 66_CD (_( HSV-_NNP 1_CD
          genome_NN containing_VBG a_DT LacZ_NNP insertion_NN within_IN the_DT 
          pol_NN coding_VBG region_NN )_) viral_JJ DNA_NNP was_VBD
          kindly_RB provided_VBN by_IN D_NNP ._. Coen_NNP (_( Harvard_NNP University_NNP ,_, Boston_NNP ,_,
          MA_NNP )_) [_NN 17_CD ]_NN ._. HP_NNP 66_CD viral_JJ stocks_NNS were_VBD prepared_VBN by_IN
          transfecting_VBG HP_NNP 66_CD viral_JJ DNA_NNP into_IN PolB_NNP 3_CD cells_NNS ,_, which_WDT allow_VBP
          for_IN virus_NN propagation_NN by_IN expressing_VBG the_DT viral_JJ
          polymerase_NN ._.
        
        
          In_IN vitro_NN susceptibility_NN assays_NNS
          The_DT 
          tk_NN mutagenesis_NNS assay_NN was_VBD performed_VBN
          in_IN MRC_NNP 5_CD and_CC Vero_NNP cells_NNS as_IN described_VBN previously_RB [_NN 10_CD 21_CD ]_NN
          ._. The_DT proportion_NN of_IN resistant_JJ virus_NN referred_VBD to_TO as_IN
          mutation_NN frequency_NN or_CC error_NN frequency_NN throughout_IN this_DT
          study_NN was_VBD calculated_VBN as_IN follows_VBZ :_: (_( titer_NN in_IN the_DT presence_NN
          of_IN drug_NN )_) /_NN (_( titer_NN in_IN the_DT absence_NN of_IN drug_NN )_) ×_NN 100_CD ._.
        
        
          Construction_NNP of_IN recombinant_JJ viruses_NNS
          Marker_NNP transfer_VB experiments_NNS involved_VBD co-transfection_JJ
          of_IN HSV-_NNP 2_CD 
          pol_NN coding_VBG region_NN (_( HSV-_NNP 2_CD SB_NNP 5_CD ,_, HSV-_NNP 2_CD
          83_CD D_NNP ,_, HSV-_NNP 2_CD 6652_CD and_CC HSV-_NNP 2_CD 6757_CD described_VBD in_IN [_NN 21_CD ]_NN )_) with_IN
          HP_NNP 66_CD viral_JJ DNA_NNP into_IN Vero_NNP cells_NNS ._. Recombinant_NNP virus_NN was_VBD
          plaque_NN purified_JJ to_TO homogeneity_NN in_IN the_DT presence_NN of_IN X-G_NNP al_NN ._.
          The_DT 
          pol_NN coding_VBG region_NN from_IN the_DT
          recombinant_JJ viruses_NNS was_VBD confirmed_VBN to_TO be_VB identical_JJ to_TO
          their_PRP$ respective_JJ parental_JJ virus_NN 
          pol_NN sequences_NNS by_IN terminator_NN cycle_NN
          sequencing_VBG using_VBG an_DT automated_VBN model_NN 377_CD DNA_NNP sequencer_NN
          (_( Perkin_NNP Elmer_NNP ,_, Applied_NNP Biosystems_NNP )_) ._.
        
        
          Virus_NNP growth_NN analysis_NN
          To_TO compare_VB the_DT ability_NN of_IN parental_JJ viruses_NNS and_CC
          recombinant_JJ viruses_NNS to_TO replicate_VB in_IN Vero_NNP cells_NNS with_IN that_DT
          of_IN the_DT wild_JJ type_NN HSV-_NNP 2_CD SB_NNP 5_CD strain_NN ,_, 3_CD ×_NN 10_CD 5_CD Vero_NNP cells_NNS
          were_VBD infected_VBN with_IN each_DT virus_NN at_IN a_DT multiplicity_NN of_IN
          infection_NN of_IN 5_CD PFU_NNP per_IN cell_NN ._. Virus_NNP progeny_NN were_VBD harvested_VBN
          at_IN different_JJ time_NN points_NNS and_CC titered_JJ on_IN Vero_NNP cells_NNS ._. All_DT
          viruses_NNS yielded_VBD similar_JJ PFU_NNP /_NN ml_NN (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Plasmid_NNP construction_NN
          A_DT non-_NN HSV_NNP gene_NN template_NN (_( pSV_NN 110_CD )_) was_VBD constructed_VBN by_IN
          taking_VBG the_DT plasmid_NN pSVβgal_NN (_( Promega_NNP )_) and_CC inserting_VBG the_DT
          HSV-_NNP 1_CD origin_NN of_IN replication_NN (_( ori_NN 
          S_NNP )_) SmaI_NNP fragment_NN [_NN 5_CD ]_NN ._. The_DT plasmid_NN
          pTK_NN 1_CD contains_VBZ HSV-_NNP 1_CD SC_NNP 16_CD sequence_NN coordinates_VBZ
          45_CD ,_, 055_CD -_: 48_CD ,_, 634_CD subcloned_JJ into_IN the_DT HindIII_NNP /_NN EcoRI_NNP site_NN of_IN
          pUC_NN 19_CD (_( Invitrogen_NNP )_) ._. The_DT plasmid_NN pTK_NN 2_CD contains_VBZ HSV-_NNP 2_CD SB_NNP 5_CD
          sequence_NN coordinates_VBZ 44_CD ,_, 469_CD -_: 48_CD ,_, 184_CD subcloned_JJ into_IN the_DT
          HindIII_NNP /_NN EcoRI_NNP site_NN of_IN pUC_NN 19_CD ._. The_DT plasmid_NN pLacZ_NN contains_VBZ
          the_DT LacZ_NNP coding_VBG region_NN from_IN pSVβgal_NN subcloned_JJ into_IN the_DT
          HindIII_NNP /_NN EcoRI_NNP site_NN of_IN pUC_NN 19_CD ._.
        
        
          Transient_NNP replication_NN /_NN rescue_NN assay_NN
          Vero_NNP cells_NNS were_VBD seeded_VBN at_IN 3_CD ×_NN 10_CD 5_CD cells_NNS per_IN 2_CD mL_NN well_RB
          in_IN a_DT six_CD well_RB plate_NN and_CC incubated_JJ overnight_JJ at_IN 37_CD °_NN C_NNP ._. The_DT
          following_VBG day_NN ,_, cells_NNS were_VBD transfected_JJ with_IN 1_CD ._. 5_CD μg_NN of_IN
          pSV_NN 110_CD and_CC 1_CD μg_NN of_IN salmon_NN sperm_NN DNA_NNP using_VBG Lipofectamine_NNP
          reagent_NN according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS
          (_( Invitrogen_NNP )_) ._. Following_VBG overnight_JJ incubation_NN at_IN 37_CD °_NN C_NNP ,_, the_DT
          medium_NN was_VBD removed_VBN and_CC virus_NN inoculated_JJ at_IN an_DT MOI_NNP =_SYM 5_CD in_IN
          2_CD mL_NN volume_NN for_IN 1_CD h_NN ._. Following_VBG overnight_JJ incubation_NN at_IN
          37_CD °_NN C_NNP ,_, the_DT cells_NNS demonstrated_VBD CPE_NNP and_CC the_DT infected-cell_JJ
          monolayer_NN was_VBD rinsed_JJ twice_RB with_IN 1_CD X_NNP phosphate_NN buffered_JJ
          saline_NN ._. Next_JJ ,_, cell_NN monolayers_NNS were_VBD lysed_JJ by_IN scraping_VBG into_IN
          1_CD ._. 0_CD mL_NN of_IN lysis_NNS buffer_NN (_( 0_CD ._. 6_CD %_NN SDS_NNP ,_, 0_CD ._. 01_CD M_NNP EDTA_NNP pH_NN 7_CD ._. 5_LS )_) per_IN
          well_RB ._. The_DT infected_JJ cell_NN lysate_NN was_VBD adjusted_VBN to_TO a_DT final_JJ
          concentration_NN of_IN 1_CD M_NNP NaCl_NNP ,_, inverted_JJ 10_CD X_NNP and_CC stored_VBD at_IN 4_CD °_NN C_NNP
          overnight_JJ ._. The_DT samples_NNS were_VBD centrifuged_JJ at_IN 14_CD ,_, 000_CD rpm_NN for_IN
          10_CD minutes_NNS at_IN 4_CD °_NN C_NNP and_CC the_DT supernatant_NN was_VBD collected_VBN ,_,
          treated_VBN with_IN 100_CD μg_NN /_NN ml_NN RNAse_NNP at_IN 37_CD °_NN C_NNP for_IN one_CD hour_NN ._.
          Following_VBG that_DT incubation_NN ,_, 100_CD μg_NN /_NN mL_NN Proteinase_NNP K_NNP was_VBD
          added_VBN and_CC samples_NNS were_VBD incubated_JJ at_IN 50_CD °_NN C_NNP for_IN 2_CD hours_NNS ._.
          After_IN several_JJ phenol-chloroform_JJ extractions_NNS ,_, the_DT DNA_NNP was_VBD
          precipitated_VBD ,_, centrifuged_JJ at_IN 14_CD ,_, 000_CD rpm_NN for_IN 10_CD minutes_NNS at_IN
          4_CD °_NN C_NNP and_CC the_DT pellets_NNS resuspended_JJ in_IN 50_CD μl_NN water_NN and_CC
          incubated_JJ at_IN 37_CD °_NN C_NNP for_IN 2_CD hours_NNS ._. To_TO remove_VB non-replicated_JJ
          templates_NNS ,_, 2_CD ._. 5_CD μg_NN of_IN infected_JJ cell_NN DNA_NNP was_VBD digested_VBN with_IN 
          Dpn_NNP I_PRP and_CC precipitated_VBD ,_, centrifuged_JJ
          at_IN 14_CD ,_, 000_CD rpm_NN for_IN 10_CD minutes_NNS at_IN 4_CD °_NN C_NNP and_CC resuspended_JJ in_IN 20_CD
          μl_NN dH_NN 
          2_CD O_NNP ._. One-fourth_NNP of_IN the_DT 
          DpnI_NNP -_: treated_VBN DNA_NNP was_VBD transformed_VBN
          into_IN DH_NNP 5_CD α_NN cells_NNS (_( recombination-deficient_JJ bacterial_JJ cells_NNS ;_:
          Invitrogen_NNP )_) ._. The_DT transformation_NN mix_NN was_VBD plated_JJ onto_IN
          several_JJ LB-AMP_NNP plates_NNS containing_VBG Xgal_NNP and_CC isopropyl_NN β-_NN D_NNP
          thiogalactoside_NN (_( IPTG_NNP )_) ._. The_DT number_NN of_IN blue_JJ colonies_NNS
          (_( indicating_VBG no_DT mutation_NN in_IN β_NN galactosidase_NN gene_NN )_) and_CC
          white_JJ colonies_NNS (_( indicating_VBG mutation_NN within_IN β_NN
          galactosidase_NN gene_NN or_CC promoter_NN )_) were_VBD determined_VBN ._. An_DT
          average_NN of_IN 300_CD ,_, 000_CD colonies_NNS were_VBD recovered_VBN from_IN three_CD
          independent_JJ experiments_NNS for_IN each_DT virus_NN infection_NN ._. Two_CD
          control_NN samples_NNS were_VBD included_VBN in_IN each_DT experiment_NN to_TO
          normalize_VB for_IN mutations_NNS induced_VBN by_IN transfection_NN or_CC
          superinfection_NN processes_NNS ._. For_IN the_DT transfection_NN control_NN ,_,
          pSV_NN 110_CD was_VBD transfected_JJ into_IN Vero_NNP cells_NNS ,_, mock-infected_JJ and_CC
          directly_RB transformed_VBN into_IN bacteria_NNS for_IN blue_JJ /_NN white_JJ colony_NN
          screening_NN ._. For_IN the_DT superinfection_NN control_NN ,_, pSV_NN 110_CD was_VBD
          transfected_JJ into_IN Vero_NNP cells_NNS ,_, superinfected_JJ with_IN HP_NNP 66_CD
          Pol-mutant_NNP virus_NN (_( which_WDT is_VBZ unable_JJ to_TO replicate_VB )_) and_CC
          transformed_VBN into_IN bacteria_NNS for_IN blue_JJ /_NN white_JJ colony_NN
          screening_NN ._. For_IN the_DT controls_NNS ,_, both_DT DpnI_NNP and_CC non-_NN DpnI_NNP
          treated_VBD samples_NNS were_VBD anlayzed_JJ ._. The_DT values_NNS in_IN Table_NNP 2_CD are_VBP
          presented_VBN as_IN mutation_NN frequency_NN which_WDT is_VBZ (_( number_NN of_IN white_JJ
          colonies_NNS from_IN test_NN sample_NN /_NN number_NN of_IN blue_JJ colonies_NNS from_IN
          test_NN sample_NN )_) -_: (_( number_NN of_IN white_JJ colonies_NNS from_IN HP_NNP 66_CD
          superinfection_NN sample_NN /_NN number_NN of_IN blue_JJ colonies_NNS from_IN HP_NNP 66_CD
          superinfection_NN sample_NN )_) ×_NN 100_CD ._.
        
        
          S_NNP 1_CD nuclease_NN digestion_NN assay_NN
          Supercoiled_NNP plasmids_NNS (_( 5_CD μg_NN )_) were_VBD treated_VBN with_IN 3_CD units_NNS
          S_NNP 1_CD nuclease_NN or_CC mock-treated_JJ ,_, in_IN S_NNP 1_CD nuclease_NN buffer_NN
          (_( Invitrogen_NNP )_) containing_VBG 100_CD mM_NN final_JJ concentration_NN of_IN
          NaCl_NNP ,_, for_IN 5_CD min_NN at_IN 37_CD °_NN C_NNP ._. Reactions_NNP were_VBD stopped_VBN by_IN
          performing_VBG two_CD phenol_NN ,_, and_CC two_CD phenol-chloroform_JJ
          extractions_NNS ._. DNA_NNP was_VBD precipitated_VBD with_IN ethanol_NN ,_,
          centrifuged_JJ and_CC resuspended_JJ in_IN dH_NN 
          2_CD O_NNP for_IN digestion_NN with_IN restriction_NN
          enzymes_NNS as_IN indicated_VBN ._. Restriction_NNP digested_VBN samples_NNS were_VBD
          electrophoresed_JJ on_IN a_DT 0_CD ._. 8_CD %_NN agarose_NN gel_NN and_CC stained_JJ with_IN
          ethidium_NN bromide_NN for_IN visualization_NN ._. Two_CD separate_JJ plasmid_NN
          purifications_NNS were_VBD utilized_JJ for_IN this_DT study_NN ,_, with_IN similar_JJ
          results_NNS ._.
        
      
      
        Results_NNS
        
          Pol-recombinant_NNP viruses_NNS
          HSV-_NNP 2_CD 
          pol_NN (_( SB_NNP 5_CD ,_, 83_CD D_NNP ,_, 6652_CD and_CC 6757_CD
          described_VBD in_IN [_NN 21_CD ]_NN )_) or_CC HSV-_NNP 1_CD 
          pol_NN (_( SC_NNP 16_CD and_CC PAA_NNP r_LS 5_LS )_) coding_VBG
          regions_NNS were_VBD co-transfected_JJ with_IN replication_NN defective_JJ
          HP_NNP 66_CD viral_JJ DNA_NNP containing_VBG a_DT LacZ_NNP insertion_NN within_IN 
          pol_NN [_NN 17_CD ]_NN into_IN Vero_NNP cells_NNS to_TO
          generate_VB recombinant_JJ viruses_NNS ._. Recombinant_NNP viruses_NNS were_VBD
          successfully_RB obtained_VBN for_IN all_DT pols_NNS except_IN wild_JJ type_NN HSV-_NNP 1_CD
          SC_NNP 16_CD and_CC the_DT low_JJ error_NN rate_NN or_CC antimutator_NN HSV-_NNP 1_CD PAA_NNP r_LS 5_CD [_NN
          10_CD ]_NN ._. The_DT 
          pol_NN -_: recombinant_JJ viruses_NNS were_VBD
          plaque-purified_JJ and_CC the_DT 
          pol_NN genes_NNS completely_RB sequenced_JJ
          along_IN with_IN those_DT of_IN their_PRP$ parental_JJ viruses_NNS to_TO confirm_VB the_DT
          recombination_NN event_NN ._. Three_CD of_IN the_DT HSV-_NNP 2_CD viruses_NNS ,_, HSV-_NNP 2_CD
          SB_NNP 5_CD ,_, HSV-_NNP 2_CD 6652_CD and_CC HSV-_NNP 2_CD 83_CD D_NNP ,_, had_VBD 
          pol_NN sequences_NNS consistent_JJ with_IN wild_JJ
          type_NN isolates_VBZ found_VBN in_IN GeneBank_NNP and_CC were_VBD recently_RB
          characterized_VBN [_NN 21_CD ]_NN ._.
          The_DT 
          pol_NN from_IN HSV-_NNP 2_CD 6757_CD ,_, a_DT virus_NN which_WDT
          showed_VBD a_DT 300_CD -_: to_TO 700_CD -_: fold_VB higher_JJR error_NN rate_NN than_IN HSV-_NNP 1_CD
          SC_NNP 16_CD by_IN the_DT 
          tk_NN mutagenesis_NNS assay_NN previously_RB [_NN
          21_CD ]_NN ,_, was_VBD found_VBN to_TO contain_VB three_CD mutations_NNS compared_VBN to_TO
          the_DT other_JJ HSV-_NNP 2_CD 
          pols_NNS ,_, with_IN one_CD change_NN residing_VBG in_IN
          region_NN VII_NNP which_WDT is_VBZ shared_VBN among_IN diverse_JJ DNA_NNP polymerases_NNS
          (_( Fig_NNP ._. 1_LS )_) ._. No_DT amino_JJ acid_NN changes_NNS were_VBD identified_VBN within_IN
          the_DT proofreading_VBG (_( Exo_NNP )_) domains_NNS ._. The_DT high_JJ frequency_NN of_IN
          errors_NNS generated_VBN by_IN HSV-_NNP 2_CD 6757_CD did_VBD not_RB appear_VB to_TO preclude_VB
          its_PRP$ ability_NN to_TO replicate_VB efficiently_RB in_IN culture_NN ._. In_IN fact_NN ,_,
          no_DT significant_JJ differences_NNS in_IN the_DT growth_NN curve_NN of_IN
          parental_JJ and_CC recombinant_JJ viruses_NNS in_IN Vero_NNP cells_NNS (_( compared_VBN
          to_TO wild_JJ type_NN HSV-_NNP 2_CD SB_NNP 5_LS )_) were_VBD apparent_JJ (_( data_NNS not_RB
          shown_VBN )_) ._.
        
        
          tkmutagenesis_NNS assay_NN
          The_DT proportions_NNS of_IN virus_NN resistant_JJ to_TO ACV_NNP or_CC PCV_NNP ,_,
          which_WDT arise_VBP during_IN amplification_NN of_IN virus_NN stocks_NNS in_IN the_DT
          absence_NN of_IN drug_NN selection_NN ,_, were_VBD measured_VBN by_IN the_DT method_NN
          described_VBN by_IN Hall_NNP et_CC al_NN ._. [_NN 10_CD ]_NN ._. Plating_NNP efficiency_NN
          assays_NNS were_VBD performed_VBN in_IN MRC-_NNP 5_CD cells_NNS at_IN 3_CD μg_NN /_NN ml_NN ACV_NNP ,_,
          which_WDT is_VBZ 10_CD -_: times_NNS higher_JJR than_IN the_DT average_JJ IC_NNP 
          50_CD for_IN HSV-_NNP 1_CD SVC_NNP 16_CD ,_, and_CC at_IN 8_CD μg_NN /_NN ml_NN
          ACV_NNP ,_, which_WDT is_VBZ 10_CD -_: times_NNS higher_JJR than_IN the_DT average_JJ IC_NNP 
          50_CD for_IN the_DT panel_NN of_IN HSV-_NNP 2_CD viruses_NNS ._.
          Notably_RB ,_, whereas_IN the_DT four_CD HSV-_NNP 2_CD parental_JJ viruses_NNS had_VBD
          spontaneous_JJ mutation_NN frequencies_NNS significantly_RB higher_JJR
          than_IN HSV-_NNP 1_CD isolates_VBZ (_( Table_NNP 1_LS )_) ,_, the_DT frequency_NN of_IN errors_NNS
          from_IN 
          pol_NN -_: recombinant_JJ viruses_NNS expressing_VBG
          an_DT HSV-_NNP 2_CD Pol_NNP in_IN an_DT HSV-_NNP 1_CD background_NN were_VBD
          indistinguishable_JJ from_IN HSV-_NNP 1_CD SC_NNP 16_CD when_WRB tested_VBN in_IN MRC-_NNP 5_CD
          cells_NNS ._. In_IN fact_NN ,_, three_CD of_IN the_DT type_NN 2_CD 
          pol_NN -_: recombinant_JJ viruses_NNS ,_, SB_NNP 5_CD PR_NNP ,_,
          6652_CD PR_NNP and_CC 83_CD DPR_NNP ,_, had_VBD error_NN rates_NNS equal_JJ to_TO or_CC slightly_RB
          lower_JJR than_IN HSV-_NNP 1_CD SC_NNP 16_CD (_( 0_CD ._. 05_CD %_NN )_) ._. Results_NNS were_VBD similar_JJ for_IN
          plating_VBG efficiency_NN with_IN PCV_NNP (_( data_NNS not_RB shown_VBN )_) ._. In_IN this_DT
          assay_NN ,_, the_DT HSV-_NNP 2_CD Pol_NNP does_VBZ not_RB appear_VB to_TO be_VB solely_RB
          responsible_JJ for_IN the_DT difference_NN in_IN drug-resistant_JJ
          spontaneous_JJ 
          tk_NN mutations_NNS observed_VBD between_IN HSV-_NNP 1_CD
          and_CC HSV-_NNP 2_CD strains_NNS ._.
          Interestingly_RB ,_, unlike_IN the_DT other_JJ 
          pol_NN -_: recombinant_JJ viruses_NNS ,_, 6757_CD PR_NNP ,_,
          containing_VBG the_DT 
          pol_NN coding_VBG region_NN from_IN the_DT
          supermutator_NN clinical_JJ isolate_VB HSV-_NNP 2_CD 6757_CD ,_, retained_VBD a_DT high_JJ
          spontaneous_JJ mutation_NN frequency_NN ._. This_DT recombinant_JJ virus_NN
          showed_VBD a_DT sixty-fold_JJ increase_NN in_IN mutation_NN frequency_NN
          compared_VBN to_TO HSV-_NNP 1_CD SC_NNP 16_CD (_( Table_NNP 1_LS )_) ._. This_DT increase_NN in_IN errors_NNS
          is_VBZ most_RBS likely_JJ the_DT direct_JJ result_NN of_IN the_DT mutations_NNS
          identified_VBN within_IN the_DT 
          pol_NN coding_VBG region_NN and_CC suggests_VBZ that_IN
          this_DT virus_NN may_MD indeed_RB possess_VB a_DT Pol_NNP defect_NN in_IN replication_NN
          fidelity_NN ._. The_DT fact_NN that_IN the_DT 6757_CD PR_NNP mutation_NN frequency_NN was_VBD
          3_CD -_: 5_CD %_NN ,_, whilst_NN parental_JJ HSV-_NNP 2_CD 6757_CD was_VBD 20_CD -_: 28_CD %_NN ,_, implicates_NNS
          the_DT target_NN /_NN template_NN or_CC other_JJ viral_JJ proteins_NNS in_IN modulating_VBG
          spontaneous_JJ mutations_NNS ._.
        
        
          Drug-independent_NNP mutation_NN frequency_NN using_VBG non-_NN HSV_NNP
          DNA_NNP
          To_TO eliminate_VB any_DT contribution_NN of_IN drug_NN selection_NN or_CC 
          tk_NN gene_NN template_NN on_IN the_DT spontaneous_JJ
          mutation_NN frequency_NN in_IN the_DT 
          tk_NN mutagenesis_NNS assay_NN ,_, non_NN
          drug-selected_JJ HSV_NNP replication-dependent_JJ mutations_NNS within_IN
          an_DT unrelated_JJ prokaryotic_JJ gene_NN were_VBD measured_VBN using_VBG a_DT LacZ_NNP
          shuttle_NN plasmid_NN assay_NN ._. This_DT assay_NN employed_VBN transfection_NN
          of_IN a_DT plasmid_NN containing_VBG the_DT 230_CD bp_NN SmaI_NNP fragment_NN of_IN ori_NN 
          s_VBZ ,_, the_DT HSV_NNP origin_NN of_IN replication_NN ,_, and_CC
          a_DT LacZ_NNP reporter_NN gene_NN ,_, into_IN Vero_NNP cells_NNS ._. This_DT plasmid_NN was_VBD
          confirmed_VBN to_TO generate_VB DpnI-resistant_NNP progeny_NN in_IN Vero_NNP
          cells_NNS upon_IN superinfection_NN with_IN the_DT wild_JJ type_NN HSV-_NNP 1_CD and_CC
          HSV-_NNP 2_CD (_( data_NNS not_RB shown_VBN )_) ._. After_IN superinfection_NN ,_, 
          DpnI_NNP -_: resistant_JJ (_( non-methylated_JJ ;_:
          replicated_VBN )_) plasmid_NN DNA_NNP was_VBD rescued_VBD in_IN 
          E_NNP ._. coli_NNS ._. In_IN the_DT presence_NN of_IN X-G_NNP al_NN ,_,
          bacterial_JJ colonies_NNS which_WDT turn_VBP blue_JJ do_VBP not_RB contain_VB
          mutations_NNS in_IN the_DT LacZ_NNP promoter_NN or_CC LacZ_NNP coding_VBG region_NN ._.
          However_RB ,_, colonies_NNS remaining_VBG white_JJ contain_VB mutations_NNS to_TO
          impair_VB LacZ_NNP expression_NN ._.
          Mutations_NNP can_MD be_VB introduced_VBN during_IN replication_NN by_IN the_DT
          viral_JJ proteins_NNS or_CC also_RB by_IN the_DT mutagenic_JJ processes_NNS of_IN
          transfection_NN and_CC viral_JJ infection_NN ._. Since_IN the_DT process_NN of_IN
          transfection_NN is_VBZ often_RB mutagenic_JJ ,_, pSV_NN 110_CD was_VBD transfected_JJ
          into_IN Vero_NNP cells_NNS ,_, mock-infected_JJ and_CC rescued_VBD into_IN bacteria_NNS
          to_TO determine_VB background_NN frequency_NN of_IN mutation_NN from_IN the_DT
          experimental_JJ process_NN ._. Transfection_NNP was_VBD found_VBN to_TO confer_VB a_DT
          mutation_NN frequency_NN less_JJR than_IN 0_CD ._. 002_CD %_NN (_( 6_CD white_JJ colonies_NNS in_IN
          over_IN 300_CD ,_, 000_CD total_JJ colonies_NNS )_) after_IN analyzing_VBG non-_NN DpnI_NNP
          treated_VBD samples_NNS ._. No_DT colonies_NNS were_VBD recovered_VBN when_WRB treating_VBG
          the_DT rescued_VBD DNA_NNP with_IN DpnI_NNP ._. Moreover_RB ,_, to_TO ensure_VB that_IN viral_JJ
          replication_NN ,_, and_CC not_RB simply_RB the_DT process_NN of_IN viral_JJ
          infection_NN ,_, is_VBZ responsible_JJ for_IN the_DT mutations_NNS in_IN a_DT rescued_VBD
          plasmid_NN ,_, a_DT control_NN transfection-superinfection_JJ was_VBD
          performed_VBN using_VBG the_DT 
          pol_NN mutant_JJ ,_, HP_NNP 66_CD ,_, which_WDT is_VBZ unable_JJ
          to_TO replicate_VB ._. The_DT mutation_NN frequency_NN contributed_VBD directly_RB
          from_IN the_DT process_NN of_IN viral_JJ infection_NN was_VBD 0_CD ._. 12_CD %_NN (_( 335_CD in_IN
          over_IN 280_CD ,_, 000_CD colonies_NNS )_) after_IN analyzing_VBG non-_NN DpnI_NNP treated_VBD
          samples_NNS ._. Less_JJR than_IN 25_CD colonies_NNS were_VBD recovered_VBN when_WRB
          treating_VBG the_DT rescued_VBD DNA_NNP with_IN DpnI_NNP ._. The_DT data_NNS presented_VBN in_IN
          Table_NNP 2_CD was_VBD normalized_JJ by_IN subtracting_VBG the_DT mutation_NN
          frequency_NN for_IN HP_NNP 66_CD infection_NN (_( 0_CD ._. 12_CD %_NN )_) ._.
          The_DT relative_JJ mutation_NN frequency_NN for_IN the_DT panel_NN of_IN
          viruses_NNS tested_VBN in_IN the_DT non-_NN HSV_NNP DNA_NNP mutagenesis_NNS assay_NN are_VBP
          presented_VBN in_IN Table_NNP 2_CD ._. Consistent_NNP with_IN recent_JJ data_NNS from_IN
          Hwang_NNP et_CC al_NN ._. [_NN 13_CD ]_NN ,_, PAA_NNP r_LS 5_CD showed_VBD a_DT minor_JJ increase_NN in_IN
          mutation_NN frequency_NN ,_, compared_VBN with_IN wild_JJ type_NN HSV-_NNP 1_CD and_CC
          HSV-_NNP 2_CD (_( Table_NNP 2_LS )_) ._. The_DT presence_NN of_IN an_DT antimutator_NN phenotype_NN
          with_IN this_DT viral_JJ polymerase_NN in_IN the_DT 
          tk_NN mutagenesis_NNS assay_NN was_VBD not_RB
          apparent_JJ when_WRB using_VBG the_DT non-_NN HSV_NNP DNA_NNP mutagenesis_NNS assay_NN ,_,
          and_CC therefore_RB phenotype-labelling_JJ may_MD be_VB dependent_JJ upon_IN
          both_DT the_DT assay_NN method_NN and_CC /_NN or_CC the_DT target_NN gene_NN ._. Moreover_RB ,_,
          the_DT panel_NN of_IN wild_JJ type_NN HSV-_NNP 2_CD viruses_NNS and_CC the_DT PR_NNP viruses_NNS
          in_IN this_DT LacZ_NNP phenotypic_JJ assay_NN had_VBD mutation_NN frequencies_NNS
          similar_JJ or_CC below_IN that_DT of_IN wild_JJ type_NN HSV-_NNP 1_CD SC_NNP 16_CD ._. Thus_RB ,_, the_DT
          high_JJ proportion_NN of_IN errors_NNS associated_VBN with_IN HSV-_NNP 2_CD viruses_NNS
          appears_VBZ specific_JJ to_TO the_DT 
          tk_NN mutagenesis_NNS assay_NN ._.
          HSV-_NNP 2_CD 6757_CD ,_, although_IN not_RB 6757_CD PR_NNP ,_, conferred_VBD a_DT slightly_RB
          higher_JJR proportion_NN of_IN mutations_NNS in_IN non-_NN HSV_NNP DNA_NNP in_IN the_DT
          plasmid_NN assay_NN ,_, than_IN wild_JJ type_NN HSV-_NNP 1_CD and_CC HSV-_NNP 2_CD ,_, consistent_JJ
          with_IN a_DT mutator_NN phenotype_NN ._. Sequencing_NNP of_IN the_DT Pol_NNP encoded_JJ
          from_IN HSV-_NNP 2_CD 6757_CD confirmed_VBD several_JJ residue_NN changes_NNS which_WDT
          may_MD contribute_VB to_TO the_DT higher_JJR error_NN rate_NN ,_, although_IN the_DT
          direct_JJ relationship_NN of_IN these_DT individual_JJ mutations_NNS within_IN
          the_DT 
          pol_NN coding_VBG region_NN to_TO decreased_VBD Pol_NNP
          fidelity_NN has_VBZ not_RB been_VBN confirmed_VBN (_( Figure_NN 1_LS )_) ._. It_PRP remains_VBZ
          unclear_JJ whether_IN a_DT conserved_JJ residue_NN change_NN (_( Lys_NNP to_TO Arg_NNP at_IN
          943_CD )_) in_IN region_NN VII_NNP ,_, a_DT motif_NN purported_JJ to_TO participate_VB in_IN
          the_DT recognition_NN of_IN the_DT PPi_NNP and_CC nucleotide_NN substrates_NNS [_NN 27_CD
          ]_NN ,_, or_CC whether_IN one_CD or_CC more_JJR of_IN the_DT other_JJ three_CD residue_NN
          changes_NNS identified_VBN in_IN HSV-_NNP 2_CD 6757_CD 
          pol_NN cooperate_VB to_TO affect_VB mutation_NN
          frequency_NN ._.
        
        
          Anisomorphic_NNP DNA_NNP conformations_NNS
          Reiterated_NNP sequence_NN elements_NNS are_VBP often_RB observed_VBN to_TO
          form_VB an_DT unwound_NN S_NNP 1_CD nuclease-sensitive_JJ DNA_NNP conformation_NN ,_,
          termed_VBD anisomorphic_JJ or_CC left-handed_JJ DNA_NNP ,_, when_WRB present_JJ in_IN
          negatively_RB supercoiled_JJ plasmids_NNS [_NN 22_CD 24_CD ]_NN ._.
          Nuclease-sensitive_NNP secondary_JJ structures_NNS within_IN the_DT HSV_NNP
          origin_NN of_IN replication_NN are_VBP believed_VBN to_TO be_VB recognized_VBN by_IN
          the_DT viral_JJ origin_NN binding_JJ protein_NN ,_, and_CC mutations_NNS that_WDT
          reduce_VBP this_DT complex_JJ formation_NN in_IN vitro_NN also_RB reduce_VB viral_JJ
          replication_NN ,_, thereby_RB indicating_VBG that_IN localized_JJ torsional_NN
          strain_NN may_MD occur_VB during_IN viral_JJ DNA_NNP replication_NN [_NN 1_CD ]_NN ._. The_DT
          
          tk_NN mutagenesis_NNS assay_NN measures_NNS
          replication-dependent_JJ mutation_NN frequency_NN within_IN the_DT 
          tk_NN gene_NN ,_, whereas_IN the_DT non-_NN HSV_NNP DNA_NNP
          mutagenesis_NNS assay_NN measures_VBZ errors_NNS within_IN a_DT bacterial_JJ LacZ_NNP
          gene_NN ._. Three_CD pUC-based_JJ plasmids_NNS were_VBD examined_VBN for_IN the_DT
          potential_NN to_TO form_VB S_NNP 1_CD nuclease_NN sensitive_JJ structures_NNS :_: pTK_NN 1_CD
          which_WDT contains_VBZ a_DT 3_CD ._. 6_CD Kb_NNP HSV-_NNP 1_CD DNA_NNP fragment_NN including_VBG the_DT 
          tk_NN coding_VBG region_NN ,_, pTK_NN 2_CD containing_VBG a_DT
          3_CD ._. 7_CD Kb_NNP HSV-_NNP 2_CD DNA_NNP fragment_NN including_VBG the_DT 
          tk_NN coding_VBG region_NN ,_, and_CC pLacZ_NN which_WDT
          contains_VBZ the_DT 3_CD ._. 4_CD Kb_NNP LacZ_NNP coding_VBG region_NN ._. These_DT negatively_RB
          supercoiled_JJ plasmids_NNS were_VBD treated_VBN with_IN S_NNP 1_CD nuclease_NN or_CC
          mock-treated_JJ for_IN 5_CD min_NN ._. After_IN removal_NN of_IN the_DT nuclease_NN ,_,
          the_DT plasmids_NNS were_VBD linearized_JJ with_IN HindIII_NNP ._. Figure_NN 2_CD shows_VBZ
          that_DT treatment_NN of_IN pTK_NN 1_CD and_CC pLacZ_NN with_IN S_NNP 1_CD nuclease_NN did_VBD not_RB
          alter_VB the_DT restriction_NN enzyme_NN profile_NN ,_, suggesting_VBG that_IN in_IN
          this_DT assay_NN ,_, the_DT formation_NN of_IN S_NNP 1_CD nuclease-sensitive_JJ
          structures_NNS was_VBD below_IN the_DT level_NN of_IN detection_NN (_( Fig_NNP ._. 2_LS ,_,
          lanes_NNS 3_CD -_: 6_CD )_) ._. However_RB ,_, pTK_NN 2_CD was_VBD readily_RB digested_VBN with_IN S_NNP 1_CD
          nuclease_NN ,_, which_WDT resulted_VBD in_IN the_DT appearance_NN of_IN four_CD novel_NN
          bands_NNS suggesting_VBG two_CD potential_JJ nuclease-hypersensitive_JJ
          sites_NNS (_( Fig_NNP ._. 2_LS ,_, lane_NN 2_LS )_) ._. Additional_JJ restriction_NN mapping_NN
          studies_NNS suggest_VBP that_IN the_DT hypersensitive_JJ regions_NNS are_VBP
          within_IN the_DT viral_JJ DNA_NNP fragment_NN ,_, and_CC not_RB in_IN pUC_NN DNA_NNP (_( data_NNS
          not_RB shown_VBN )_) ._.
        
      
      
        Discussion_NNP
        The_DT 
        tk_NN mutagenesis_NNS assay_NN has_VBZ been_VBN
        utilized_JJ by_IN ourselves_PRP and_CC others_NNS [_NN 10_CD 13_CD ]_NN to_TO determine_VB
        both_DT frequency_NN and_CC spectrum_NN of_IN mutations_NNS in_IN the_DT HSV_NNP 
        tk_NN gene_NN following_VBG selection_NN for_IN drug_NN
        resistance_NN ._. In_IN this_DT study_NN ,_, we_PRP have_VBP extended_VBN the_DT findings_NNS of_IN
        previous_JJ work_NN [_NN 13_CD ]_NN by_IN using_VBG 
        pol_NN -_: recombinant_JJ viruses_NNS to_TO examine_VB
        mutation_NN frequency_NN in_IN HSV_NNP ._. Specifically_RB ,_, this_DT study_NN
        evaluated_VBD the_DT contribution_NN of_IN type_NN 2_CD polymerase_NN to_TO mutation_NN
        frequency_NN when_WRB measured_VBN by_IN the_DT 
        tk_NN mutagenesis_NNS and_CC non-_NN HSV_NNP DNA_NNP
        mutagenesis_NNS assays_NNS ._.
        The_DT control_NN viruses_NNS ,_, HSV-_NNP 2_CD 6757_CD and_CC HSV-_NNP 1_CD PAA_NNP r_LS 5_CD ,_,
        demonstrated_VBN mutator_NN or_CC antimutator_NN phenotypes_NNS ,_,
        respectively_RB ,_, in_IN the_DT 
        tk_NN mutagenesis_NNS assay_NN ,_, but_CC not_RB in_IN the_DT
        non-_NN HSV_NNP DNA_NNP mutagenesis_NNS assay_NN ._. Thus_RB ,_, classification_NN of_IN a_DT 
        pol_NN gene_NN as_IN mutator_NN (_( HSV-_NNP 2_CD 6757_CD )_) or_CC
        antimutator_NN (_( PAA_NNP r_LS 5_LS )_) is_VBZ not_RB a_DT general_JJ characteristic_NN ,_, but_CC
        is_VBZ likely_JJ dependent_JJ upon_IN the_DT assay_NN method_NN and_CC target_NN gene_NN ._.
        This_DT observation_NN is_VBZ consistent_JJ with_IN the_DT recent_JJ report_NN of_IN
        high_JJ mutation_NN frequency_NN within_IN the_DT 
        SupF_NNP gene_NN upon_IN replication_NN by_IN PAA_NNP r_LS 5_CD
        [_NN 13_CD ]_NN ._.
        Since_IN the_DT control_NN viruses_NNS described_VBD above_IN functioned_VBD as_IN
        expected_VBN in_IN the_DT tk_NN mutagenesis_NNS assay_NN ,_, recombinant_JJ viruses_NNS
        expressing_VBG the_DT HSV-_NNP 2_CD polymerase_NN within_IN an_DT HSV-_NNP 1_CD genome_NN were_VBD
        also_RB examined_VBN ._. Interestingly_RB ,_, three_CD wild_JJ type_NN HSV-_NNP 2_CD
        polymerases_NNS (_( 6652_CD ,_, 83_CD D_NNP and_CC SB_NNP 5_LS )_) showed_VBD mutation_NN frequencies_NNS
        similar_JJ to_TO HSV-_NNP 1_CD SC_NNP 16_CD ,_, rather_RB than_IN their_PRP$ parental_JJ virus_NN ,_,
        when_WRB placed_VBN within_IN an_DT HSV-_NNP 1_CD genome_NN ._. Only_RB HSV-_NNP 2_CD 6757_CD
        maintained_VBD a_DT high_JJ error_NN rate_NN (_( 60_CD -_: fold_VB )_) over_IN that_DT of_IN HSV-_NNP 1_CD
        SC_NNP 16_CD ,_, when_WRB placed_VBN within_IN an_DT HSV-_NNP 1_CD genome_NN ._. However_RB ,_, the_DT
        mutation_NN frequency_NN of_IN this_DT recombinant_JJ virus_NN (_( HSV-_NNP 2_CD 6757_CD PR_NNP )_)
        was_VBD not_RB completely_RB penetrant_NN when_WRB compared_VBN to_TO the_DT parental_JJ
        HSV-_NNP 2_CD 6757_CD virus_NN ,_, which_WDT showed_VBD a_DT 400_CD -_: fold_VB higher_JJR percent_NN of_IN
        resistant_JJ mutants_NNS compared_VBN to_TO HSV-_NNP 1_CD SC_NNP 16_CD ._.
        An_DT important_JJ distinguishing_VBG factor_NN between_IN the_DT 
        tk_NN mutagenesis_NNS and_CC LacZ_NNP test_NN systems_NNS
        is_VBZ the_DT use_NN of_IN antiviral_JJ selectors_NNS to_TO measure_VB mutation_NN
        frequency_NN ._. Silent_NNP mutations_NNS within_IN the_DT 
        tk_NN gene_NN that_WDT do_VBP not_RB impair_VB
        susceptibility_NN to_TO antiviral_JJ agents_NNS ,_, or_CC mutations_NNS resulting_VBG
        in_IN lethality_NN of_IN the_DT virus_NN ,_, would_MD escape_VB detection_NN as_IN a_DT
        mutation_NN in_IN the_DT 
        tk_NN mutagenesis_NNS assay_NN ._. Futhermore_NNP ,_, the_DT
        DNA_NNP sequence_NN being_VBG replicated_VBN is_VBZ unique_JJ between_IN these_DT
        systems_NNS and_CC this_DT could_MD contribute_VB to_TO the_DT differences_NNS in_IN
        mutation_NN frequency_NN between_IN assay_NN systems_NNS ._. The_DT demonstration_NN
        of_IN S_NNP 1_CD nuclease-sensitive_JJ sites_NNS within_IN the_DT type_NN 2_CD viral_JJ
        genome_NN overlapping_VBG the_DT tk_NN coding_VBG region_NN ,_, and_CC the_DT absence_NN of_IN
        such_JJ sites_NNS in_IN the_DT type_NN 1_CD viral_JJ genome_NN ,_, suggest_VBP that_IN local_JJ
        topology_NN may_MD be_VB different_JJ between_IN these_DT HSV-_NNP 1_CD and_CC HSV-_NNP 2_CD ._.
        Although_IN the_DT potential_JJ contribution_NN of_IN this_DT
        supercoiling-induced_JJ phenomenon_NN to_TO modulate_VBP mutation_NN
        frequency_NN during_IN viral_JJ replication_NN is_VBZ unclear_JJ ,_, it_PRP could_MD
        partially_RB explain_VB why_WRB the_DT type_NN 2_CD polymerases_NNS confer_VBP a_DT high_JJ
        mutation_NN frequency_NN to_TO HSV-_NNP 2_CD genomes_NNS and_CC a_DT low_JJ mutation_NN
        frequency_NN when_WRB placed_VBN within_IN an_DT HSV-_NNP 1_CD genome_NN ._. Changes_NNS in_IN
        local_JJ topology_NN could_MD contribute_VB to_TO polymerase_NN slippage_NN and_CC
        the_DT incorporation_NN of_IN errors_NNS ._.
        The_DT inability_NN of_IN type_NN 2_CD viruses_NNS to_TO confer_VB a_DT higher_JJR
        mutation_NN rate_NN than_IN type_NN 1_CD viruses_NNS in_IN the_DT non-_NN HSV_NNP DNA_NNP
        mutagenesis_NNS assay_NN is_VBZ consistent_JJ with_IN the_DT absence_NN of_IN S_NNP 1_CD
        nuclease_NN hypersensitive_JJ sites_NNS in_IN the_DT LacZ_NNP gene_NN fragment_NN ._.
        Furthermore_RB ,_, the_DT HSV-_NNP 2_CD 
        tk_NN sequence_NN used_VBD herein_NN contained_VBD
        almost_RB 69_CD %_NN G-C_NNP content_NN ,_, compared_VBN to_TO the_DT HSV-_NNP 1_CD 
        tk_NN which_WDT has_VBZ 65_CD %_NN of_IN bases_NNS as_IN G_NNP or_CC C_NNP ._.
        Melting_NNP temperature_NN alone_RB may_MD not_RB contribute_VB to_TO the_DT
        difference_NN in_IN S_NNP 1_CD nuclease_NN sensitivity_NN ._. However_RB ,_, alignment_NN
        of_IN the_DT 
        tk_NN sequences_NNS showed_VBD that_IN the_DT type_NN 2_CD
        gene_NN had_VBD at_IN least_JJS eight_CD distinct_JJ stretches_VBZ containing_VBG
        between_IN 7_CD and_CC 13_CD G-C_NNP bases_NNS ,_, whereas_IN the_DT overlapping_VBG region_NN
        in_IN the_DT type_NN 1_CD 
        tk_NN had_VBD four_CD or_CC less_JJR G-C_NNP bases_NNS ._. This_DT
        differential_NN in_IN more_JJR extensive_JJ G-C_NNP rich_JJ regions_NNS supports_VBZ
        the_DT observations_NNS reported_VBD herein_NN ._.
        The_DT data_NNS presented_VBD herein_NN clearly_RB demonstrate_VB that_DT
        polymerase_NN alone_RB may_MD not_RB account_VB for_IN the_DT high_JJ mutation_NN
        frequency_NN associated_VBN with_IN type_NN 2_CD viruses_NNS in_IN the_DT tk_NN
        mutagenesis_NNS assay_NN ._. In_IN addition_NN to_TO the_DT potential_JJ impact_NN of_IN
        target_NN sequence_NN and_CC secondary_JJ structure_NN topology_NN on_IN
        mutation_NN frequency_NN ,_, other_JJ viral_JJ replicative_JJ proteins_NNS
        including_VBG Pol_NNP accessory_JJ protein_NN ,_, TK_NNP ,_, dUTPase_NN ,_, and_CC
        uracil-_NN DNA_NNP glycosylase_NN may_MD cooperate_VB with_IN Pol_NNP to_TO modulate_VBP
        polymerase_NN repair_NN and_CC nucleotide_NN selection_NN [_NN 12_CD 13_CD 19_CD 23_CD ]_NN
        ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
    
  
